Replimune Group, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Patel Sushil | Chief Executive Officer | Award / Grant | 200,000 | — | — | 533,576 | Dec 19, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Award / Grant | 60,000 | — | — | 199,685 | Dec 19, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Award / Grant | 60,000 | — | — | 194,368 | Dec 19, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Award / Grant | 35,000 | — | — | 158,088 | Dec 19, 2025 |
| Schwendenman Andrew | Chief Accounting Officer | Award / Grant | 10,000 | — | — | 78,284 | Dec 19, 2025 |
| Dhingra Kapil | — | Option Exercise | 3,169 | $1.75 | $5,546 | 3,169 | Dec 9, 2025 |
| Patel Sushil | Chief Executive Officer | Sale | 10,000 | $11.13 | $111,300 | 333,576 | Dec 2, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 5,208 | $9.10 | $47,393 | 123,088 | Nov 17, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 7,248 | $9.10 | $65,957 | 139,685 | Nov 17, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Sale | 9,154 | $5.37 | $49,157 | 134,368 | Aug 15, 2025 |
| Astley-Sparke Philip | — | Sale | 32,279 | $8.06 | $260,169 | 1,405,071 | May 20, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 7,952 | $8.06 | $64,093 | 146,933 | May 20, 2025 |
| Schwendenman Andrew | Chief Accounting Officer | Sale | 3,287 | $8.05 | $26,460 | 68,284 | May 20, 2025 |
| Patel Sushil | Chief Executive Officer | Sale | 25,105 | $8.06 | $202,346 | 343,576 | May 20, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Sale | 2,535 | $8.05 | $20,407 | 143,522 | May 20, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 3,749 | $8.05 | $30,179 | 128,296 | May 20, 2025 |
| Patel Sushil | Chief Executive Officer | Award / Grant | 166,667 | — | — | 368,681 | Apr 1, 2025 |
| Xynos Konstantinos | Chief Medical Officer | Award / Grant | 45,000 | — | — | 154,885 | Apr 1, 2025 |
| Hill Emily Luisa | Chief Financial Officer | Award / Grant | 45,000 | — | — | 146,057 | Apr 1, 2025 |
| Sarchi Christopher | Chief Commercial Officer | Award / Grant | 45,000 | — | — | 132,045 | Apr 1, 2025 |
| Schwendenman Andrew | Chief Accounting Officer | Award / Grant | 33,333 | — | — | 71,571 | Apr 1, 2025 |
| Patel Sushil | Chief Executive Officer | Sale | 10,000 | $12.42 | $124,200 | 202,014 | Dec 16, 2024 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 7,246 | $10.78 | $78,112 | 109,885 | Nov 18, 2024 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 5,207 | $10.78 | $56,131 | 87,045 | Nov 18, 2024 |
| Astley-Sparke Philip | Executive Chairman | Gift | 50,000 | — | — | 1,437,350 | Aug 30, 2024 |
| Hill Emily Luisa | Chief Financial Officer | Sale | 8,938 | $10.18 | $90,989 | 101,057 | Aug 16, 2024 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 15,881 | $7.50 | $119,108 | 117,131 | Jun 7, 2024 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 2,218 | $6.47 | $14,350 | 92,252 | May 16, 2024 |
| Schwendenman Andrew | Chief Accounting Officer | Sale | 2,298 | $6.47 | $14,868 | 38,238 | May 16, 2024 |
| Love Colin | Chief Operating Officer | Sale | 17,615 | $6.47 | $113,969 | 777,345 | May 16, 2024 |
| Astley-Sparke Philip | Executive Chairman | Sale | 37,928 | $6.47 | $245,394 | 1,487,350 | May 16, 2024 |
| Coffin Robert | — | Sale | 11,464 | $6.47 | $74,172 | 1,821,872 | May 16, 2024 |
| Patel Sushil | Chief Executive Officer | Sale | 20,194 | $6.47 | $130,655 | 212,014 | May 16, 2024 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 6,367 | $6.47 | $41,194 | 133,012 | May 16, 2024 |
| Patel Sushil | Chief Executive Officer | Award / Grant | 83,335 | — | — | 232,208 | Apr 1, 2024 |
| Xynos Konstantinos | Chief Medical Officer | Award / Grant | 26,665 | — | — | 139,379 | Apr 1, 2024 |
| Hill Emily Luisa | Chief Financial Officer | Award / Grant | 26,665 | — | — | 109,995 | Apr 1, 2024 |
| Sarchi Christopher | Chief Commercial Officer | Award / Grant | 22,225 | — | — | 94,470 | Apr 1, 2024 |
| Schwendenman Andrew | Chief Accounting Officer | Award / Grant | 17,775 | — | — | 40,536 | Apr 1, 2024 |
| Xynos Konstantinos | Chief Medical Officer | Sale | 7,313 | $10.92 | $79,858 | 112,714 | Nov 16, 2023 |
| Sarchi Christopher | Chief Commercial Officer | Sale | 5,255 | $10.92 | $57,385 | 72,245 | Nov 16, 2023 |
| Hill Emily Luisa | Chief Financial Officer | Award / Grant | 83,330 | — | — | 83,330 | Sep 18, 2023 |
| Esposito Pamela | Chief Business Officer | Sale | 5,358 | $20.01 | $107,214 | 263,436 | Sep 11, 2023 |
| Esposito Pamela | Chief Business Officer | Sale | 18,600 | $20.01 | $372,186 | 263,436 | Aug 22, 2023 |
| Esposito Pamela | Chief Business Officer | Sale | 1,400 | $20.00 | $28,000 | 263,436 | Aug 11, 2023 |
| Esposito Pamela | Chief Business Officer | Sale | 2,077 | $21.12 | $43,866 | 263,436 | Jul 10, 2023 |
| Lewis Tanya | Chief Dev. Op. Officer | Sale | 817 | $23.45 | $19,159 | 135,293 | Jun 13, 2023 |
| Patel Sushil | Chief Strategy Officer | Sale | 553 | $23.44 | $12,962 | 148,873 | Jun 13, 2023 |
| Patel Sushil | Chief Strategy Officer | Sale | 15,575 | $18.05 | $281,129 | 154,571 | May 16, 2023 |
| Coffin Robert | President & Chief R&D Officer | Sale | 7,861 | $18.05 | $141,891 | 1,833,336 | May 16, 2023 |